EVAX Facility

The EVAX facility was upfitted to meet our product requirements. Approximately The EVAX facility is ~3,500 square feet of manufacturing space in the West Virginia University Innovation Corporation—previously the Mylan-Viatris solid oral dose manufacturing site in Morgantown, WV. Our space was customized to support the specialized extraction and production of triterpene oils and adjuvant formulation. These processes are configured for scalability and flexibility with analytical laboratories co-located to facilitate process refinement.

Enepret Laboratories

Enepret Incorporated is the EVAX parent company. Founded in 2017 to commercialize the underlying triteprene production technologies developed in Dr. Joe Chappell's laboratory at the University of Kentucky. Enepret continues to develop technologies for triterpene production but also adjuvant and vaccine technologies as pipeline products for EVAX.   Located in Lexington, KY it enjoys a close relationship with the University of Kentucky and other world-class collaborators in the United States and internationally.